222 related articles for article (PubMed ID: 16420065)
1. Synthesis and in vitro antileukemic activity of some new 1,3-(oxytetraethylenoxy)cyclotriphosphazene derivatives.
Siwy M; Sek D; Kaczmarczyk B; Jaroszewicz I; Nasulewicz A; Pelczyñska M; Nevozhay D; Opolski A
J Med Chem; 2006 Jan; 49(2):806-10. PubMed ID: 16420065
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro antiproliferative activity of new 1,3-(oxytetraethylenoxy)-cyclotriphosphazene derivatives.
Siwy M; Sek D; Kaczmarczyk B; Wietrzyk J; Nasulewicz A; Opolski A
Anticancer Res; 2007; 27(3B):1553-8. PubMed ID: 17595775
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro cytostatic activity of some new 1,3-(oxytetraethylenoxy)-cyclotriphosphazatriene derivatives.
Porwolik-Czomperlik I; Siwy M; Sek D; Kaczmarczyk B; Nasulewicz A; Jaroszewicz I; Pełczyńska M; Opolski A
Acta Pol Pharm; 2004; 61(4):267-72. PubMed ID: 15580683
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiproliferative activity of 1,4-bis(dimethylamino)-9,10-anthraquinone derivatives against P388 mouse leukemic tumor cells.
Jin GZ; Jin HS; Jin LL
Arch Pharm Res; 2011 Jul; 34(7):1071-6. PubMed ID: 21811913
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, antitumor evaluation and DNA photocleaving activity of novel methylthiazonaphthalimides with aminoalkyl side chains.
Li Z; Yang Q; Qian X
Bioorg Med Chem Lett; 2005 Jun; 15(12):3143-6. PubMed ID: 15876532
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, antitumor activity, molecular modeling, and DNA binding properties of a new series of imidazonaphthalimides.
Braña MF; Cacho M; García MA; de Pascual-Teresa B; Ramos A; Acero N; Llinares F; Muñoz-Mingarro D; Abradelo C; Rey-Stolle MF; Yuste M
J Med Chem; 2002 Dec; 45(26):5813-6. PubMed ID: 12477366
[TBL] [Abstract][Full Text] [Related]
7. Bis-naphthylureas and related compounds: synthesis, chemical properties, DNA affinity and antineoplastic activity.
Bruno AM; Asis SE; Gaozza CH
Pharmazie; 2001 May; 56(5):361-5. PubMed ID: 11400549
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of novel bis-anthraquinone derivatives and their biological evaluation as antitumor agents.
Taher AT; Hegazy GH
Arch Pharm Res; 2013 May; 36(5):573-8. PubMed ID: 23471561
[TBL] [Abstract][Full Text] [Related]
9. Novel thiazonaphthalimides as efficient antitumor and DNA photocleaving agents: effects of intercalation, side chains, and substituent groups.
Li Z; Yang Q; Qian X
Bioorg Med Chem; 2005 Aug; 13(16):4864-70. PubMed ID: 15925513
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antiproliferative assay of norcantharidin derivatives in cancer cells.
Tu GG; Zhan JF; Lv QL; Wang JQ; Kuang BH; Li SH
Med Chem; 2014 Jun; 10(4):376-81. PubMed ID: 23909288
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor evaluation of symmetrical 1,5-diamidoanthraquinone derivatives as compared to their disubstituted homologues.
Huang HS; Chiu HF; Tao CW; Chen IB
Chem Pharm Bull (Tokyo); 2006 Apr; 54(4):458-64. PubMed ID: 16595945
[TBL] [Abstract][Full Text] [Related]
12. Annulation of substituted anthracene-9,10-diones yields promising selectively antiproliferative compounds.
Castro-Castillo V; Suárez-Rozas C; Castro-Loiza N; Theoduloz C; Cassels BK
Eur J Med Chem; 2013 Apr; 62():688-92. PubMed ID: 23454511
[TBL] [Abstract][Full Text] [Related]
13. Cyclopent[a]anthraquinones as DNA intercalating agents with covalent bond formation potential: synthesis and biological activity.
Kim JY; Su TL; Chou TC; Koehler B; Scarborough A; Ouerfelli O; Watanabe KA
J Med Chem; 1996 Jul; 39(14):2812-8. PubMed ID: 8709111
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity correlations of the cytotoxic bifunctional 1,4-diamidoanthraquinone derivatives.
Huang HS; Chiu HF; Lee AL; Guo CL; Yuan CL
Bioorg Med Chem; 2004 Dec; 12(23):6163-70. PubMed ID: 15519160
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and cytotoxicity of a salicylihalamide A analogue.
Tang S; Erickson KL
J Nat Prod; 2008 May; 71(5):898-901. PubMed ID: 18407694
[TBL] [Abstract][Full Text] [Related]
16. Bis-naphthalimides: a new class of antitumor agents.
Braña MF; Castellano JM; Morán M; Pérez de Vega MJ; Romerdahl CR; Qian XD; Bousquet P; Emling F; Schlick E; Keilhauer G
Anticancer Drug Des; 1993 Aug; 8(4):257-68. PubMed ID: 8240655
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and cytotoxic effect of hydroxy- and 3-alkylaminopropoxy-9,10-anthraquinone derivatives.
Teng CH; Won SJ; Lin CN
Bioorg Med Chem; 2005 May; 13(10):3439-45. PubMed ID: 15848756
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and biological evaluation of a potent salicylihalamide A lactam analogue.
Balan D; Burns CJ; Fisk NG; Hügel H; Huang DC; Segal D; White C; Wagler J; Rizzacasa MA
Org Biomol Chem; 2012 Oct; 10(40):8147-53. PubMed ID: 22964776
[TBL] [Abstract][Full Text] [Related]
19. Amides of pyrrole- and thiophene-fused anthraquinone derivatives: A role of the heterocyclic core in antitumor properties.
Tikhomirov AS; Litvinova VA; Andreeva DV; Tsvetkov VB; Dezhenkova LG; Volodina YL; Kaluzhny DN; Treshalin ID; Schols D; Ramonova AA; Moisenovich MM; Shtil AA; Shchekotikhin AE
Eur J Med Chem; 2020 Aug; 199():112294. PubMed ID: 32428792
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Anti-Proliferative Activity of Sulfanyltriazolylnaphthalenols and Sulfanyltriazolylnaphthalene-1,4-diones.
Chaaban I; El Khawass el SM; Abd El Razik HA; El Salamouni NS; Redondo-Horcajo M; Barasoain I; Díaz JF; Yli-Kauhaluoma J; Moreira VM
Arch Pharm (Weinheim); 2016 Sep; 349(9):749-61. PubMed ID: 27404773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
